Peter Svanqvist

Counsel, Stockholm



Peter Svanqvist is a Counsel in our Bank Finance practice in Stockholm and joined White & Case in 2018.

Prior to joining White & Case, Peter Svanqvist worked as Legal Counsel for Large Corporate & Financial Institutions at Skandinaviska Enskilda Banken AB (publ), which is one of the leading financial institutions in the Nordic region. Prior to this, he worked as a senior associate at a leading Swedish law firm and as a law clerk at the Administrative Court in Stockholm.

Juris kandidat
Stockholm University


European Master in Law and Economics
Erasmus University Rotterdam

The Netherlands

DU Europeen en Analyse Economique du Droit
Université d'Aix-Marseille III




Representation of Vizrt Group AS, as issuer, a world leading provider of visual storytelling tools for media content creators, owned by the private equity firm Nordic Capital, on the issuance of US$125 million senior secured callable bonds due 2026 governed by Norwegian law. Vizrt Group used the proceeds from the bonds to refinance its outstanding bonds and for general corporate purposes. The White & Case team also assisted on the amendment and restatement of a $40 million Multi-Currency Revolving Credit Facility provided by the bank Nordea.

Representation of Karo Pharma AB, a portfolio company of the private equity firm EQT, that specializes in the sale and marketing of prescription pharmaceuticals and over-the-counter products, with the financing of the EUR 58 million acquisition of the remaining European rights to the Pevaryl® brand portfolio from Cilag GmbH International, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Representation of a consortium consisting of Altor, Strawberry Equities (Petter Stordalen) and TDR on the acquisition of the Spanish hotel operator Airtours Resort Ownership España S.L. (AROE) as an add-on to Nordic Leisure Travel Group (Vinggruppen; f.k.a. Thomas Cook Northern Europe).

Representation of Adelis Equity Partners (Adelis) on its acquisition of Säkra AB. Säkra is one of Sweden's strongest brands in insurance brokerage and financial advisory to private individuals, business owners and the public sector.

Representation of the underwriters and syndicate banks in relation to the new €950 million financing arranged in connection with the combination of Tieto Corporation and EVRY ASA consisting of a bridge loan facility, a term loan facility and a revolving credit facility.

Representation of listed EQT portfolio company Karo Pharma AB on its SEK 3.4 billion (US$360 million) acquisition of Trimb Holding from Avista Capital Partners and other shareholders.

Representation of EQT Mid Market on the SEK 18.25 billion (€1.71 billion) sale of IP-Only to EQT Infrastructure as well as an earn-out of up to SEK 1 billion (€94 million).

Representation of Industrial and Commercial Bank of China as bridge lender on €846 million acquisition facilities for Jin Jiang International Holdings Co. to support the acquisition of Radisson Group, one of the world’s largest hotel groups with seven distinctive hotel brands with more than 1,400 hotels in destinations around the world, from HNA Hotel Group.

Representation of European Entertainment Intressenter BidCo AB (EE Intressenter) on the public cash offer to the shareholders in Cherry AB to acquire all Cherry shares at a price of SEK 87 per share.

Representation of Skandinaviska Enskilda Banken AB (publ) on the SEK 541,000,000 term and revolving facilities agreement made available to Projektengagemang Sweden AB (publ) in connection with the acquisition of Integra Engineering AB. Projektengagemang Sweden AB (publ) is a NASDAQ Stockholm-listed consultancy group specialising in urban planning and industry.

Representation of European Entertainment Intressenter BidCo AB (EE Intressenter) on the public cash offer to the shareholders in Cherry AB to acquire all Cherry shares at a price of SEK 87 per share.

Representation of BNP Paribas Fortis SA/NV, Coöperatieve Rabobank U.A., trading as Rabobank London, ING Bank N.V., Royal Bank of Canada and Sumitomo Mitsui Banking Corporation Europe Limited, as mandated lead arrangers and bookrunners, on a strategic €400 million syndicated cov-lite financing to Kiwa, a global specialist in testing, inspection and certification (TIC).

Representation of EQT on the public cash offer to the shareholders of Karo Pharma.